The Role of Orthosteric Building Blocks of Bitopic Ligands for Muscarinic M1 Receptors.


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
15 Dec 2020
Historique:
received: 31 08 2020
accepted: 16 11 2020
entrez: 21 12 2020
pubmed: 22 12 2020
medline: 22 12 2020
Statut: epublish

Résumé

The muscarinic M

Identifiants

pubmed: 33344823
doi: 10.1021/acsomega.0c04220
pmc: PMC7745449
doi:

Types de publication

Journal Article

Langues

eng

Pagination

31706-31715

Informations de copyright

© 2020 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

ACS Chem Biol. 2015 Aug 21;10(8):1797-804
pubmed: 26006698
J Mol Biol. 1997 Apr 4;267(3):727-48
pubmed: 9126849
ACS Pharmacol Transl Sci. 2020 Sep 02;3(5):859-867
pubmed: 33073186
J Med Chem. 2015 Jan 22;58(2):560-76
pubmed: 25478907
Nature. 2013 Nov 14;503(7475):295-9
pubmed: 24121438
Drug Discov Today Technol. 2013 Summer;10(2):e245-52
pubmed: 24050275
Crit Rev Neurobiol. 1996;10(1):69-99
pubmed: 8853955
Mol Inform. 2015 Aug;34(8):526-30
pubmed: 27490498
Neuropharmacology. 2010 Feb;58(2):365-73
pubmed: 19835892
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Alzheimer Dis Assoc Disord. 1997;11 Suppl 4:S16-22
pubmed: 9339268
Nat Neurosci. 2003 Jan;6(1):51-8
pubmed: 12483218
J Med Chem. 1965 Mar;8:274-5
pubmed: 14332685
Neuropharmacology. 2018 Jul 1;136(Pt C):427-437
pubmed: 28935216
Nat Chem Biol. 2020 Mar;16(3):240-249
pubmed: 32080630
J Med Chem. 2019 Apr 25;62(8):3784-3839
pubmed: 30351004
ACS Chem Biol. 2017 Jul 21;12(7):1743-1748
pubmed: 28585805
Mol Pharmacol. 1999 Dec;56(6):1245-53
pubmed: 10570052
Behav Brain Res. 2015;287:96-9
pubmed: 25800972
Mol Pharmacol. 2014 Aug;86(2):180-92
pubmed: 24870405
Med Res Rev. 2010 May;30(3):463-549
pubmed: 19557759
Bioorg Med Chem. 2007 Dec 15;15(24):7626-37
pubmed: 17889543
Nature. 2013 Feb 14;494(7436):185-94
pubmed: 23407534
J Pharmacol Exp Ther. 2015 Dec;355(3):442-50
pubmed: 26446308
J Pharmacol Exp Ther. 2018 Jan;364(1):28-37
pubmed: 29025977
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15950-5
pubmed: 19717450
Neurodegener Dis. 2008;5(3-4):237-40
pubmed: 18322400
Science. 1987 Jul 31;237(4814):527-32
pubmed: 3037705
J Biol Chem. 2016 Jul 29;291(31):16375-89
pubmed: 27298318
Nat Rev Drug Discov. 2018 Apr;17(4):243-260
pubmed: 29302067
J Med Chem. 2006 Jan 12;49(1):366-72
pubmed: 16392821
Exp Neurol. 2000 Jun;163(2):495-529
pubmed: 10833325
J Neurosci. 1995 May;15(5 Pt 2):4077-92
pubmed: 7751967
Mol Pharmacol. 1995 Jan;47(1):88-98
pubmed: 7838137
ACS Chem Neurosci. 2017 Mar 15;8(3):435-443
pubmed: 28141924
J Clin Invest. 2017 Feb 1;127(2):487-499
pubmed: 27991860
J Biol Chem. 2014 Aug 22;289(34):23817-37
pubmed: 25006252
Bioorg Med Chem Lett. 2014 Mar 1;24(5):1417-20
pubmed: 24485781
ACS Chem Biol. 2017 Mar 17;12(3):833-843
pubmed: 28117571
Nat Commun. 2012;3:1044
pubmed: 22948826
Nat Rev Drug Discov. 2014 Jul;13(7):549-60
pubmed: 24903776
Br J Pharmacol. 2013 May;169(2):357-70
pubmed: 23062057
Nature. 2016 Mar 17;531(7594):335-40
pubmed: 26958838
J Biol Chem. 2014 Feb 28;289(9):6067-79
pubmed: 24443568
Bioorg Med Chem. 1999 Aug;7(8):1539-47
pubmed: 10482446
Drug Discov Today. 2008 Jan;13(1-2):23-9
pubmed: 18190860
ACS Med Chem Lett. 2010 Jun 04;1(6):263-7
pubmed: 24900206
Trends Neurosci. 1989 Apr;12(4):148-51
pubmed: 2470172
Mol Pharmacol. 2002 Jun;61(6):1297-302
pubmed: 12021390
Angew Chem Int Ed Engl. 2017 Jun 12;56(25):7282-7287
pubmed: 28510314
Trends Pharmacol Sci. 2013 Jan;34(1):59-66
pubmed: 23177916
Psychopharmacology (Berl). 2015 Jun;232(11):1859-66
pubmed: 25491927
Mol Pharmacol. 2018 Jun;93(6):645-656
pubmed: 29695609
Sci Rep. 2018 Nov 21;8(1):17179
pubmed: 30464299
J Neurosci. 1988 Dec;8(12):4646-52
pubmed: 3199198
J Med Chem. 2009 Jul 23;52(14):4257-65
pubmed: 19499921
Am J Physiol. 1993 Jun;264(6 Pt 1):C1625-30
pubmed: 8392804
Br J Pharmacol. 2020 Jul;177(13):2923-2931
pubmed: 32052419
Neuropsychopharmacology. 2019 Apr;44(5):950-960
pubmed: 30089885
Nat Rev Mol Cell Biol. 2018 Oct;19(10):638-653
pubmed: 30104700
Pharmacol Ther. 2008 Feb;117(2):232-43
pubmed: 18082893
Am J Physiol. 1995 Jun;268(6 Pt 1):C1414-7
pubmed: 7611360

Auteurs

Daniela Volpato (D)

Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.

Michael Kauk (M)

Institute for Molecular Cell Biology, CMB-Center for Molecular Biomedicine, University Hospital Jena, Friedrich-Schiller University Jena, Hans-Knöll-Straße 2, 07745 Jena, Germany.

Regina Messerer (R)

Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.

Marcel Bermudez (M)

Institute of Pharmacy, Freie Universitaet Berlin, Königin-Luise-Str. 2-4 in 14195 Berlin-Dahlem, Germany.

Gerhard Wolber (G)

Institute of Pharmacy, Freie Universitaet Berlin, Königin-Luise-Str. 2-4 in 14195 Berlin-Dahlem, Germany.

Andreas Bock (A)

Max Delbrück Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125 Berlin, Germany.

Carsten Hoffmann (C)

Institute for Molecular Cell Biology, CMB-Center for Molecular Biomedicine, University Hospital Jena, Friedrich-Schiller University Jena, Hans-Knöll-Straße 2, 07745 Jena, Germany.

Ulrike Holzgrabe (U)

Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.

Classifications MeSH